Yury Kiselev

Vitenskapelige publikasjoner

Heger, Katrine; Skipsfjord, Julia; Kiselev, Yury; Burns, Margrete Larsen; Aaberg, Kari Modalsli; Johannessen, Svein Ivar; Skurtveit, Svetlana Ondrasova; Landmark, Cecilie Johannessen (2022). Changes in the use of antiseizure medications in children and adolescents in Norway, 2009–2018. 8 s. Epilepsy Research. Vol. 181.
https://doi.org/10.1016/j.eplepsyres.2022.106872

Kiselev, Yury; Handal, Marte; Hjellvik, Vidar; Reichborn-Kjennerud, Ted; Stoltenberg, Camilla; Suren, Pål; Havdahl, Alexandra; Skurtveit, Svetlana (2020). Nationwide study of neuropsychiatric comorbidity and medicines use in children with autism spectrum disorder in Norway. Frontiers in Psychiatry. Vol. 11.
https://doi.org/10.3389/fpsyt.2020.596032

Kiselev, Yury; Andersen, Sigve; Johannessen, Charles; Fjukstad, Bjørn; Olsen, Karina Standahl; Stenvold, Helge; Al-Saad, Samer; Dønnem, Tom; Richardsen, Elin; Bremnes, Roy M.; Busund, Lill-Tove (2018). Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer. Scientific Reports. Vol. 8.
https://doi.org/10.1038/s41598-018-23417-z

Johannessen, Charles; Moi, Line; Kiselev, Yury; Pedersen, Mona Irene; Dalen, Stig Manfred; Braaten, Tonje; Busund, Lill-Tove (2017). Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer. 22 s. PLOS ONE. Vol. 12.
https://doi.org/10.1371/journal.pone.0186658

Grindstad, Thea; Andersen, Sigve; Al-Saad, Samer; Dønnem, Tom; Kiselev, Yury; Melbø-Jørgensen, Christian; Skjefstad, Kaja; Busund, Lill-Tove; Bremnes, Roy M.; Richardsen, Elin (2015). High progesterone receptor expression in prostate cancer is associated with clinical failure. 14 s. PLOS ONE. Vol. 10:e0116691.
https://doi.org/10.1371/journal.pone.0116691

Skjefstad, Kaja; Richardsen, Elin; Dønnem, Tom; Andersen, Sigve; Kiselev, Yury; Grindstad, Thea; Hald, Sigurd; Al-Shibli, Khalid; Bremnes, Roy M.; Busund, Lill-Tove; Al-Saad, Samer (2015). The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival. Steroids. Vol. 98.
https://doi.org/10.1016/j.steroids.2015.01.020

Hald, Sigurd; Kiselev, Yury; Al-Saad, Samer; Richardsen, Elin; Johannessen, Charles; Eilertsen, Marte; Kilvær, Thomas Karsten; Al-Shibli, Khalid; Andersen, Sigve; Busund, Lill-Tove; Bremnes, Roy M.; Dønnem, Tom (2015). Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer. Vol. 15.
https://doi.org/10.1186/s12885-015-1446-z

Dønnem, Tom; Hald, Sigurd; Paulsen, Erna-Elise; Richardsen, Elin; Al-Saad, Samer; Kilvær, Thomas Karsten; Brustugun, Odd Terje; Helland, Åslaug; Lund-Iversen, Marius; Poehl, Mette; Olsen, Karen Ege; Ditzel, Henrik J.; Hansen, Olfred; Al-Shibli, Khalid; Kiselev, Yury; Sandanger, Torkjel M; Andersen, Sigve; Pezzella, Francesco; Bremnes, Roy M.; Busund, Lill-Tove (2015). Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer. 29 s. Clinical Cancer Research. Vol. 21.
https://doi.org/10.1158/1078-0432.CCR-14-1905

Eilertsen, Marte; Andersen, Sigve; Al-Saad, Samer; Kiselev, Yury; Dønnem, Tom; Stenvold, Helge; Pettersen, Ingvild; Al-Shibli, Khalid; Richardsen, Elin; Busund, Lill-Tove; Bremnes, Roy M. (2014). Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival. PLOS ONE. Vol. 9.
https://doi.org/10.1371/journal.pone.0105038

Melbø-Jørgensen, Christian Nordahl; Ness, Nora; Andersen, Sigve; Valkov, Andrey Yurjevich; Dønnem, Tom; Al-Saad, Samer; Kiselev, Yury; Berg, Thomas; Nordby, Yngve; Bremnes, Roy M.; Busund, Lill-Tove; Richardsen, Elin (2014). Stromal expression of miR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6. PLOS ONE. Vol. 9:e113039.
https://doi.org/10.1371/journal.pone.0113039

Formidling

Kiselev, Yury (2022). Pharmacovigilance in the EEA area, examples from covid-19 vaccines. 3. internasjonal konferanse i farmakologi. Kasakhstan forening for klinisk farmakologi og farmasi.

Kiselev, Yury (2022). Farmakogenetikk i norsk og verdens klinisk praksis. Nasjonal konferanse i presisjonsmedisin. Russisk akademi for medisinsk videreutdanning.

Kiselev, Yury (2022). Preanalytiske faktorer i pasientsikkerhetskonteksten. 2022 Konferanse i indremedisin. North-Western State Medical University.

Kiselev, Yury (2022). Bivirkninger av legemidler. Forskere mot myter.

Kiselev, Yury (2021). Slik jobber de med piller mot corona.
https://www.vg.no/nyheter/i/yRWxMx/slik-jobber-de-...

Kiselev, Yury (2021). Har vi lært å behandle covid bedre?.

Kiselev, Yury (2021). "Nye retningslinjer for covid behandling i Russland".
https://www.kp.ru/daily/27236/4364568/

Kiselev, Yury (2021). Implementering av antibiotikaretningslinjer i Norge. 3rd Central Asian Pharmacology Congress. Kirgisistan forening for klinisk farmakologi og farmasi.

Kiselev, Yury (2021). Farmakologisk variabilitet i klinisk praksis. 3rd Central Asian Pharmacology Congress. Kirgisistan forening for klinisk farmakologi og farmasi.

Skipsfjord, Julia; Heger, Katrine; Skurtveit, Svetlana; Aaberg, Kari Modalsli; Kiselev, Yury; Burns, Margrete Larsen; Johannessen, Svein Ivar; Landmark, Cecilie Johannessen (2021). Forbruk av antiepileptika hos barn og unge i Skandinavia-er det likt?. Norsk nevrologisk forenings årlige Nevrodager. Norsk nevrologisk forening.